Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 101-110 of 160

Page
per page
  1. ITF2357 (Givinostat)
    A4093 ITF2357 (Givinostat)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥23.8 mg/mL
  2. ZM 39923 HCl
    A4151 ZM 39923 HCl
    Target: JAK
    Summary: JAK3 inhibitor,potent and selective
  3. Lactacystin (Synthetic)
    A2583 Lactacystin (Synthetic)
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      Soluble in H2O
  4. M344
    A4105 M344
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,potent and cell-permeable
  5. Bay 11-7821 (BAY 11-7082)
    A4210 Bay 11-7821 (BAY 11-7082)
     1 Citation
    Summary: IKK/NF-κB/TNFα inhibitor
      insoluble in H2O; ≥64 mg/mL
  6. YM155
    A4221 YM155
     2 Citation
    Target: Survivin
    Summary: Survivin suppressant,apoptosis inhibitor
      ≥22.15 mg/mL
  7. Bortezomib (PS-341)
    A2614 Bortezomib (PS-341)
     24 Citation
    Target: Proteasome
    Summary: Proteasome Inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
  8. Tolcapone
    A4383 Tolcapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
      insoluble in H2O; ≥12 mg/mL
  9. BMS-509744
    A3250 BMS-509744
    Target: ITK
    Summary: Itk inhibitor,potent and selective
      Soluble in DMSO
  10. BMS-626529
    A3253 BMS-626529
     2 Citation
    Target: HIV-1 gp120
    Summary: HIV-1 attachment inhibitor
      insoluble in H2O; insoluble in EtOH; ≥1.48 mg/mL

Items 101-110 of 160

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 146item
  2. Natural Products 5item
  3. Kits 1 item
  4. Lab Reagents 4item
Reversibility
  1. Reversible 9item
  2. Irreversible 5item
Target
  1. Caspases 3item
  2. Cyclin-Dependent Kinases 6item
  3. Proteasome 4item
  4. Cathepsins 2item
  5. Histone Deacetylases (HDACs) 6item
  6. PI3K 6item
  7. CXCR 1 item
  8. Raf 4item
  9. CSF-1R 1 item
  10. EZH2 1 item
  11. mTOR 1 item
  12. MMP 1 item
  13. Peptidylprolyl isomerases 1 item
  14. Voltage-gated Potassium (KV) Channels 1 item
  15. FLT3 2item
  16. GSK-3 2item
  17. Factor Xa 1 item
  18. LPA Receptors 1 item
  19. VEGFR 6item
  20. PDGFR 5item
  21. c-Kit 2item
  22. RET 1 item
  23. p38 2item
  24. 3-phosphoglycerate dehydrogenase 1 item
  25. JNK 3item
  26. MEK 1 item
  27. FGFR 3item
  28. Liver X receptors (LXRs) 1 item
  29. Deubiquitinating enzymes (DUBs) 2item
  30. PP1 1 item
  31. PP2A 1 item
  32. Eukaryotic elongation factors 1 item
  33. Ribosomal s6 kinases (RSK) 1 item
  34. Neuraminidases (NA) 1 item
  35. MET 3item
  36. Trk Receptors 3item
  37. STAT 1 item
  38. Microtubules/Tubulins 2item
  39. Estrogen and Related Receptors 2item
  40. EGFR 1 item
  41. ROCK 2item
  42. BTK 1 item
  43. RIP kinases 1 item
  44. JAK 1 item
  45. EZH1 1 item
  46. HSP90 1 item
  47. Angiotensin AT2 Receptors 1 item
  48. Topoisomerases 2item
  49. Cytochrome P450 (CYP450) 1 item
  50. M3 Receptors 1 item
  51. S6 kinases 1 item
  52. Toll-like receptors (TLRs) 1 item
  53. Adenosine Kinases 1 item
  54. Actin 1 item
  55. Epac 1 item
  56. Survivin 1 item
  57. ERK 1 item
  58. HMG-CoA Reductases 1 item
  59. Vacuolar-type ATPase 1 item
  60. c-MET 3item
  61. PKC 1 item
  62. Calpains 1 item
  63. Ubiquitin-specific proteases 1 item
  64. RAD51 1 item
  65. Trypsins 1 item
  66. HER2 2item
  67. 5-HT2 Receptors 1 item
  68. DGAT 1 item
  69. Insulin and Insulin-like Receptors 1 item
  70. PARP 1 item
  71. ALK 2item
  72. ROS1 1 item
  73. NK1 Receptors 1 item
  74. Dehydrogenase 1 item
  75. PKG 1 item
  76. PKA 1 item
  77. Myosin light chain kinases (MLCKs) 2item
  78. HIV-1 gp120 1 item
  79. D2 Receptors 1 item
  80. Pancreatic and duodenal homeobox 1 (PDX1) 1 item
  81. Angiotensin-Converting Enzymes (ACEs) 1 item
  82. Autophagy 1 item
  83. Mixed lineage kinase domain-like protein (MLKL) 1 item
  84. COX 1 item
  85. IDH2 1 item
  86. Pregnane X Receptors 1 item
  87. GpIIb/IIIa receptor 1 item
  88. Peroxynitrite 1 item
  89. Ron 1 item
  90. Synthases/Synthetases 1 item
  91. TAK1 1 item
  92. Histamine H1 Receptors 1 item
  93. Phospholipases 1 item
  94. IL Receptors 1 item
  95. CCL2 1 item
  96. Noradrenaline reuptake 1 item
  97. Proton Pump 1 item
  98. cAMP 1 item
  99. Sulfonylurea receptors 1 item
  100. Peptidoglycan synthesis 2item
  101. Nuclear Receptors 1 item
  102. Catechol O-Methyltransferase (COMT) 1 item
  103. Angiotensin AT1 Receptors 1 item
  104. Antioxidants 1 item
  105. DREADD Ligands 1 item
  106. PP4 1 item
  107. Ub-conjugating enzyme (E2) complex 1 item
  108. PPAR 1 item
  109. IKK 1 item
  110. P97 ATPase 1 item
  111. ITK 1 item
  112. NUAK 1 item
  113. NOP Receptors 1 item
  114. PRMT 1 item
  115. Serotonin (5-HT) reuptake 1 item
  116. NE 1 item
  117. PIKfyve 1 item
Reported Experiments
  1. Animal Experiments 133item
  2. Cell Experiments 84item
Related Disease
  1. Acute Myelogenous Leukemia 3item
  2. Acute Myeloid Leukemia 2item
  3. Adrenocortical Carcinoma 1 item
  4. Bladder Cancer 3item
  5. B-lymphoid Malignancies 1 item
  6. Brain Injuries Studies 1 item
  7. Breast Cancer 21item
  8. Cancer 77item
  9. Chronic Lymphocytic Leukemia 2item
  10. Cocaine-Related Disorders 1 item
  11. Colon Cancer 8item
  12. Colorectal Cancer 11item
  13. Depression 1 item
  14. Diabetes 2item
  15. Glioblastoma 7item
  16. Glioma 5item
  17. Hepatocellular Carcinoma 3item
  18. HIV 1 item
  19. Inflammatory Diseases 3item
  20. Leukemia 1 item
  21. Lung Cancer 5item
  22. Lung Carcinoma 2item
  23. Lymphoma 7item
  24. Mantle Cell Lymphoma 2item
  25. Melanoma 8item
  26. Multiple Myeloma 5item
  27. Myeloma 2item
  28. Neuroblastoma 4item
  29. Neurocognitive Disorders 1 item
  30. Non-small Cell Lung Cancer 5item
  31. Obsessive-Compulsive Disorder 1 item
  32. Osteoporosis 1 item
  33. Ovarian Cancer 6item
  34. Pancreatic Cancer 8item
  35. Prostate Cancer 8item
  36. Renal Cancer 1 item
  37. Renal Cell Carcinoma 2item
  38. Rheumatoid Arthritis 1 item
  39. Schizophrenia 2item
  40. Thyroid Cancer 1 item
  41. Type 2 Diabetes 2item